Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense

Affiliations

• ¹ Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Clinical Epidemiology and EBM Unit and Liver Research Center, Beijing Friendship Hospital, National Clinical Research Center of Digestive Diseases, Capital Medical University, Beijing, 100050, People's Republic of China. kongyuanyuan2000@163.com.
• ² Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Clinical Epidemiology and EBM Unit and Liver Research Center, Beijing Friendship Hospital, National Clinical Research Center of Digestive Diseases, Capital Medical University, Beijing, 100050, People's Republic of China. youhong30@sina.com.
• ³ Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Clinical Epidemiology and EBM Unit and Liver Research Center, Beijing Friendship Hospital, National Clinical Research Center of Digestive Diseases, Capital Medical University, Beijing, 100050, People's Republic of China. jia_jd@ccmu.edu.cn.